Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency

Clinical trial NCT06827353 · RECRUITING

Trial details

NCT number: NCT06827353
Sponsor: Centre Hospitalier Universitaire de Nīmes
Status: RECRUITING
Study type: OBSERVATIONAL

Ovarian Carcinoma

Start date: 2020-10-01
Primary completion: 2025-05-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.